NZ531461A - Expandable gastric retention device - Google Patents
Expandable gastric retention deviceInfo
- Publication number
- NZ531461A NZ531461A NZ531461A NZ53146101A NZ531461A NZ 531461 A NZ531461 A NZ 531461A NZ 531461 A NZ531461 A NZ 531461A NZ 53146101 A NZ53146101 A NZ 53146101A NZ 531461 A NZ531461 A NZ 531461A
- Authority
- NZ
- New Zealand
- Prior art keywords
- agents
- gastric retention
- retention device
- gel
- gastric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31307801P | 2001-08-16 | 2001-08-16 | |
PCT/US2001/046146 WO2003015745A1 (en) | 2001-08-16 | 2001-10-22 | Expandable gastric retention device |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ531461A true NZ531461A (en) | 2008-03-28 |
Family
ID=23214285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ531461A NZ531461A (en) | 2001-08-16 | 2001-10-22 | Expandable gastric retention device |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1416914A1 (pt) |
JP (1) | JP2005501097A (pt) |
KR (1) | KR20040032918A (pt) |
CN (1) | CN1543337A (pt) |
BR (1) | BR0117123A (pt) |
CA (1) | CA2456976A1 (pt) |
CO (1) | CO5670360A2 (pt) |
IL (1) | IL160363A0 (pt) |
MX (1) | MXPA04001388A (pt) |
NO (1) | NO20040611L (pt) |
NZ (1) | NZ531461A (pt) |
PL (1) | PL368327A1 (pt) |
WO (1) | WO2003015745A1 (pt) |
ZA (1) | ZA200402066B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040071143A (ko) * | 2001-11-21 | 2004-08-11 | 이-지-이엠, 인코포레이티드 | 의료 또는 진단 절차에 사용하기 위한 조성물 |
EP1701705A4 (en) * | 2003-12-24 | 2007-08-08 | Advancis Pharmaceutical Corp | IMPROVED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS |
US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
CN101516408A (zh) * | 2006-07-19 | 2009-08-26 | 史密丝克莱恩比彻姆公司 | 放射性标记用于γ闪烁照相术评估的制剂的方法 |
CN102552103B (zh) * | 2010-12-20 | 2013-11-20 | 西安力邦医药科技有限责任公司 | 拉米夫定固体分散体、其制备方法、药物组合物和用途 |
EP2858604B1 (en) | 2012-06-07 | 2024-02-21 | Epitomee Medical Ltd | Expanded device |
CN105899198A (zh) | 2013-12-05 | 2016-08-24 | 图利普医疗有限公司 | 用于药物活性试剂的原位释放的滞留装置和系统 |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
RU2766335C2 (ru) | 2014-06-11 | 2022-03-15 | Массачусетс Инститьют Оф Текнолоджи | Удерживаемые структуры и связанные способы |
AU2016257711A1 (en) | 2015-05-01 | 2017-10-26 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
EP3364946A4 (en) | 2015-10-23 | 2019-06-26 | Lyndra, Inc. | STOMACH DISTRIBUTION SYSTEMS FOR DELAYED RELEASE OF THERAPEUTIC ACTIVE SUBSTANCES AND METHOD FOR THEIR USE |
EP4302817A3 (en) | 2015-12-08 | 2024-02-21 | Lyndra Therapeutics, Inc. | Geometric configurations for gastric residence systems |
JP2019532947A (ja) | 2016-09-30 | 2019-11-14 | リンドラ,インコーポレイティド | アダマンタン系薬物の持続的送達のための胃内滞留システム |
AU2018279853B2 (en) | 2017-06-09 | 2024-07-04 | Lyndra Therapeutics, Inc. | Gastric residence systems with release rate-modulating films |
CN112004520A (zh) * | 2017-12-18 | 2020-11-27 | 特瑞斯制药公司 | 包括具有触发脉冲药物释放的胃内滞留筏形成系统的调节释放药物粉末组合物 |
TR201914116A2 (tr) * | 2019-09-17 | 2021-04-21 | Univ Yeditepe | Doğal bi̇yomateryaller i̇le kri̇yojelleri̇n üreti̇m yöntemi̇ ve bu kri̇yojelleri̇n yumuşak doku i̇skelesi̇ veya i̇laç taşiyici si̇stem olarak kullanimi |
WO2022195476A1 (en) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Gastroretentive devices for assessment of intragastric conditions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
AU8699298A (en) * | 1997-08-11 | 1999-03-01 | Alza Corporation | Prolonged release active agent dosage form adapted for gastric retention |
CZ2001901A3 (cs) * | 1998-09-14 | 2001-08-15 | Ranbaxy Laboratories Limited | Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu |
JP2000256216A (ja) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | ゲル組成物 |
CA2412490A1 (en) * | 2000-06-23 | 2002-01-03 | Moshe Fleshner-Barak | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
-
2001
- 2001-10-22 IL IL16036301A patent/IL160363A0/xx unknown
- 2001-10-22 EP EP01995328A patent/EP1416914A1/en not_active Withdrawn
- 2001-10-22 WO PCT/US2001/046146 patent/WO2003015745A1/en active Application Filing
- 2001-10-22 PL PL01368327A patent/PL368327A1/xx not_active Application Discontinuation
- 2001-10-22 CA CA002456976A patent/CA2456976A1/en not_active Abandoned
- 2001-10-22 NZ NZ531461A patent/NZ531461A/en unknown
- 2001-10-22 MX MXPA04001388A patent/MXPA04001388A/es not_active Application Discontinuation
- 2001-10-22 KR KR10-2004-7002254A patent/KR20040032918A/ko not_active Application Discontinuation
- 2001-10-22 BR BR0117123-2A patent/BR0117123A/pt not_active IP Right Cessation
- 2001-10-22 JP JP2003520705A patent/JP2005501097A/ja not_active Withdrawn
- 2001-10-22 CN CNA018235441A patent/CN1543337A/zh active Pending
-
2004
- 2004-02-11 NO NO20040611A patent/NO20040611L/no not_active Application Discontinuation
- 2004-03-12 CO CO04023075A patent/CO5670360A2/es not_active Application Discontinuation
- 2004-03-15 ZA ZA200402066A patent/ZA200402066B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20040032918A (ko) | 2004-04-17 |
PL368327A1 (en) | 2005-03-21 |
BR0117123A (pt) | 2004-09-28 |
ZA200402066B (en) | 2005-05-09 |
IL160363A0 (en) | 2004-07-25 |
CA2456976A1 (en) | 2003-02-27 |
EP1416914A1 (en) | 2004-05-12 |
CN1543337A (zh) | 2004-11-03 |
NO20040611L (no) | 2004-04-16 |
JP2005501097A (ja) | 2005-01-13 |
CO5670360A2 (es) | 2006-08-31 |
WO2003015745A1 (en) | 2003-02-27 |
MXPA04001388A (es) | 2004-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040219186A1 (en) | Expandable gastric retention device | |
JP3382950B2 (ja) | 医薬品用の徐放性マトリックス | |
Gopalakrishnan et al. | Floating drug delivery systems: A Review | |
EP1750717B1 (en) | Controlled release pharmaceutical compositions with improved bioavailability | |
KR100618234B1 (ko) | 다공성 입자를 포함하는 제형 | |
AU2001268719B2 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | |
NZ531461A (en) | Expandable gastric retention device | |
JPH0830007B2 (ja) | 徐放性カプセル | |
KR20110097829A (ko) | 낮은 pH에서 불량한 수용해도를 갖는 이온화가능한 활성제의 제어 방출을 위한 고체 조성물, 및 그의 사용 방법 | |
AU2001268719A1 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | |
JP2002524494A (ja) | 一時的および空間的制御を供する経口で投与された制御薬剤送出系 | |
Vasave | A REVIEW ON: FLOATING DRUG DELIVERY SYSTEM | |
WO2022200971A1 (en) | A method for the production of gastroretentive compact matrices for the controlled release of active substances and compact matrices thus obtained | |
JP4224866B2 (ja) | 溶解時間を制御した基剤 | |
JP3122478B2 (ja) | 下部消化管放出型経口製剤 | |
AU2002225872A1 (en) | Expandable gastric retention device | |
Katakam et al. | Floating drug delivery systems: a review | |
JP6585053B2 (ja) | 胃内滞留型経口医薬組成物 | |
Singh et al. | Gastroretentive Delivery | |
WO2000016784A1 (fr) | Systeme d'administration orale de medicament permettant d'ameliorer la biodisponibilite de la glycyrrhetine activee | |
JPWO2019039420A1 (ja) | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 | |
Jaiswal Vicky et al. | FLOATING MICROSPHERE: AN APPROACH TO ORAL CONTROLLED DRUG DELIVERY VIA GASTRIC RETENTION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
PSEA | Patent sealed |